BACKGROUND: As part of the European Prospective investigation into Cancer and Nutrition (EPIC), preliminary studies were conducted to evaluate the accuracy of individuals' dietary intake measurements from newly developed questionnaires. METHODS: In six countries that adhered from the very beginning to the multicentre, co-ordinated EPIC project, the validity studies were based on two repeat questionnaire measurements at the start and at the end of a 1-year period, in groups of about 100 volunteers of both sexes. In addition, during this year, up to 12 24-hour recalls per person were taken monthly, and up to four blood and urine specimens were collected for measurement of biochemical markers. In three countries that joined EPIC later, the designs of the validity studies and type of 'reference' measurement chosen were somewhat different. The results presented in this overview paper are taken partly from more detailed, country-specific publications, and partly from a central (re-)analysis of the original data, to ensure a uniform approach to the statistical analyses and presentation. RESULTS: Averaged over subgroups by country and gender, Spearman coefficients of correlation between questionnaire measurements and the individuals' average 24-hour recalls ranged from 0.37 for fish to 0.68 for dairy products and 0.79 for alcoholic beverages. For energy-adjusted nutrient intakes (or nutrient densities, in the UK), mean Pearson correlation coefficients, corrected for residual attenuation due to day-to-day variations in the 24-hour recalls in all but two countries, ranged from 0.37 for retinol and 0.48 for vitamin E to 0.60 for carbohydrates and 0.12 for total alcohol intake. Correlations between energy-adjusted nutrient intakes and biochemical markers on average were low, but varied considerably between study centres. CONCLUSIONS: On average, most estimated correlation coefficient were of similar magnitude to those observed by independent research groups. The role of the preliminary validity studies, and various benefits drawn from these studies for further planning of the EPIC project are discussed.
BACKGROUND: As part of the European Prospective investigation into Cancer and Nutrition (EPIC), preliminary studies were conducted to evaluate the accuracy of individuals' dietary intake measurements from newly developed questionnaires. METHODS: In six countries that adhered from the very beginning to the multicentre, co-ordinated EPIC project, the validity studies were based on two repeat questionnaire measurements at the start and at the end of a 1-year period, in groups of about 100 volunteers of both sexes. In addition, during this year, up to 12 24-hour recalls per person were taken monthly, and up to four blood and urine specimens were collected for measurement of biochemical markers. In three countries that joined EPIC later, the designs of the validity studies and type of 'reference' measurement chosen were somewhat different. The results presented in this overview paper are taken partly from more detailed, country-specific publications, and partly from a central (re-)analysis of the original data, to ensure a uniform approach to the statistical analyses and presentation. RESULTS: Averaged over subgroups by country and gender, Spearman coefficients of correlation between questionnaire measurements and the individuals' average 24-hour recalls ranged from 0.37 for fish to 0.68 for dairy products and 0.79 for alcoholic beverages. For energy-adjusted nutrient intakes (or nutrient densities, in the UK), mean Pearson correlation coefficients, corrected for residual attenuation due to day-to-day variations in the 24-hour recalls in all but two countries, ranged from 0.37 for retinol and 0.48 for vitamin E to 0.60 for carbohydrates and 0.12 for total alcohol intake. Correlations between energy-adjusted nutrient intakes and biochemical markers on average were low, but varied considerably between study centres. CONCLUSIONS: On average, most estimated correlation coefficient were of similar magnitude to those observed by independent research groups. The role of the preliminary validity studies, and various benefits drawn from these studies for further planning of the EPIC project are discussed.
Authors: Nada Assi; Sabina Rinaldi; Vivian Viallon; S Ghazaleh Dashti; Laure Dossus; Agnès Fournier; Iris Cervenka; Marina Kvaskoff; Renée Turzanski-Fortner; Manuela Bergmann; Heiner Boeing; Salvatore Panico; Fulvio Ricceri; Domenico Palli; Rosario Tumino; Sara Grioni; María José Sánchez Pérez; María-Dolores Chirlaque; Catalina Bonet; Aurelio Barricarte Gurrea; Pilar Amiano Etxezarreta; Susana Merino; H Bas Bueno de Mesquita; Carla H van Gils; Charlotte Onland-Moret; Anne Tjønneland; Kim Overvad; Antonia Trichopoulou; Georgia Martimianaki; Anna Karakatsani; Tim Key; Sofia Christakoudi; Merete Ellingjord-Dale; Kostas Tsilidis; Elio Riboli; Rudolf Kaaks; Marc J Gunter; Pietro Ferrari Journal: Int J Cancer Date: 2019-04-30 Impact factor: 7.396
Authors: Isabelle Romieu; Pietro Ferrari; Veronique Chajès; Jordi de Batlle; Carine Biessy; Chiara Scoccianti; Laure Dossus; Marie Christine Boutron; Nadia Bastide; Kim Overvad; Anja Olsen; Anne Tjønneland; Rudolf Kaaks; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; Salvatore Panico; H B As Bueno-de-Mesquita; Carla H Gils; Petra H Peeters; Eiliv Lund; Guri Skeie; Elisabete Weiderpass; J Ramón Quirós; María-Dolores Chirlaque; Eva Ardanaz; María-José Sánchez; Eric J Duell; Pilar Amiano Etxezarreta; Signe Borgquist; Göran Hallmans; Ingegerd Johansson; Lena Maria Nilsson; Kay-Tee Khaw; Nick Wareham; Timothy J Key; Ruth C Travis; Neil Murphy; Petra A Wark; Elio Riboli Journal: Int J Cancer Date: 2017-01-15 Impact factor: 7.396
Authors: Isabel Fortier; Paul R Burton; Paula J Robson; Vincent Ferretti; Julian Little; Francois L'Heureux; Mylène Deschênes; Bartha M Knoppers; Dany Doiron; Joost C Keers; Pamela Linksted; Jennifer R Harris; Geneviève Lachance; Catherine Boileau; Nancy L Pedersen; Carol M Hamilton; Kristian Hveem; Marilyn J Borugian; Richard P Gallagher; John McLaughlin; Louise Parker; John D Potter; John Gallacher; Rudolf Kaaks; Bette Liu; Tim Sprosen; Anne Vilain; Susan A Atkinson; Andrea Rengifo; Robin Morton; Andres Metspalu; H Erich Wichmann; Mark Tremblay; Rex L Chisholm; Andrés Garcia-Montero; Hans Hillege; Jan-Eric Litton; Lyle J Palmer; Markus Perola; Bruce H R Wolffenbuttel; Leena Peltonen; Thomas J Hudson Journal: Int J Epidemiol Date: 2010-09-02 Impact factor: 7.196
Authors: Lisa B Signorello; Maciej S Buchowski; Qiuyin Cai; Heather M Munro; Margaret K Hargreaves; William J Blot Journal: Am J Epidemiol Date: 2010-01-08 Impact factor: 4.897
Authors: Karen Glanz; Frances McCarty; Eric J Nehl; David L O'Riordan; Peter Gies; Lucja Bundy; Adam E Locke; Dawn M Hall Journal: Am J Prev Med Date: 2008-10-21 Impact factor: 5.043
Authors: Pietro Ferrari; Heinz Freisling; Eric J Duell; Rudolf Kaaks; Leila Lujan-Barroso; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Laura Nailler; Silvia Polidoro; Amalia Mattiello; Domenico Palli; Rosario Tumino; Sara Grioni; Sven Knüppel; Anne Tjønneland; Anja Olsen; Kim Overvad; Philippos Orfanos; Michail Katsoulis; Antonia Trichopoulou; Jose Ramón Quirós; Eva Ardanaz; José María Huerta; Pilar Amiano Etxezarreta; María José Sánchez; Francesca Crowe; Kay-Tee Khaw; Nicholas J Wareham; Marga Ocke; Bas Bueno-de-Mesquita; Petra H M Peeters; Ulrika Ericson; Elisabet Wirfält; Göran Hallmans; Ingegerd Johansson; Dagrun Engeset; Geneviève Nicolas; Valentina Gallo; Teresa Norat; Elio Riboli; Nadia Slimani Journal: Eur J Nutr Date: 2012-11-01 Impact factor: 5.614
Authors: F L Büchner; H B Bueno-de-Mesquita; J Linseisen; H C Boshuizen; L A L M Kiemeney; M M Ros; K Overvad; L Hansen; A Tjonneland; O Raaschou-Nielsen; F Clavel-Chapelon; M-C Boutron-Ruault; M Touillaud; R Kaaks; S Rohrmann; H Boeing; U Nöthlings; A Trichopoulou; D Zylis; V Dilis; D Palli; S Sieri; P Vineis; R Tumino; S Panico; P H M Peeters; C H van Gils; E Lund; I T Gram; T Braaten; C Martinez; A Agudo; L Arriola; E Ardanaz; C Navarro; L Rodríguez; J Manjer; E Wirfält; G Hallmans; T Rasmuson; T J Key; A W Roddam; S Bingham; K-T Khaw; N Slimani; P Bofetta; G Byrnes; T Norat; D Michaud; E Riboli Journal: Cancer Causes Control Date: 2010-03 Impact factor: 2.506